CompletedNot Applicable

Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients

Denmark150 participantsStarted 2007-08

Plain-language summary

In stent neointimal hyperplasia may be less in the Cypher select plus stent compared to the Xience V stent in diabetic patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All diabetic patients treated with one or more drug eluting stents in the coronary arteries at one of the 5 heart centres in Denmark (Gentofte, Rigshospitalet, Odense, Skejby, Aalborg) can be included in the study. Exclusion Criteria: * The patient will not participate * The patient participates in other randomised stent studies * Expected survival \< 1 year * Allergy to Aspirin, Clopidogrel or Ticlopidine * Allergy to Sirolimus or ABT-578

What they're measuring

In stent neointimal hyperplasia

Timeframe: Within 10 months

Trial details

NCT IDNCT00552994

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-07

View on ClinicalTrials.gov More Diabetes Mellitus trials